Page 163 - 2025 Ranger Medic Handbook
P. 163

CETIRIZINE (ZYRTEC)
         Class: ENT agent – H 1 -receptor antagonist; nonsedating antihistamine
         Action: Potent H 1 -receptor antagonist and antihistamine; low lipophilicity and H 1 - receptor selectivity and thus no
         significant anticholinergic or CNS activity; reduces local and systemic effects of histamine release
         Dose: 5–10mg PO qd
         Indications: Seasonal and perennial allergic rhinitis and chronic idiopathic urticaria
         Contraindications: H 1 -receptor antihistamine hypersensitivity; pregnancy category may use during pregnancy and
         caution advised while breastfeeding
         Adverse/Side-effects: Constipation, diarrhea, dry mouth; drowsiness, sedation, headache, depression
         Interactions:  Theophylline may  decrease  clearance  leading  to toxicity;  do not  use in  combination  with  OTC
         antihistamines
         Mission Impact: GROUNDING medication for personnel on flight status


         CIMETIDINE (TAGAMET)                                                SECTION 4
         Class: GI agent – antisecretory H 2 -receptor antagonist
         Action: Antihistamine with high selectivity for reversible competitive inhibition of histamine H 2 -receptors on parietal
         cells of the stomach (minimal effect on H 1 -receptors) and thus decreases gastric acid secretion, raises the pH of the
         stomach, and indirectly reduces pepsin secretion
         Dose: Oral: 300mg QID or 800mg at bedtime or 400mg bid for up to 8 weeks
         Indications: For treatment of duodenal/gastric ulcer, prevention of ulcer recurrence, gastroesophageal reflux, chronic
         urticaria, acetaminophen toxicity
         Contraindications: H 2 -receptor antagonist hypersensitivity; pregnancy category may use during pregnancy and while
         breastfeeding
         Adverse/Side-effects:  Fever,  cardiac arrhythmias and cardiac arrest after rapid IV bolus; diarrhea, constipation,
         abdominal discomfort; increased prothrombin time, neutropenia, thrombocytopenia, aplastic anemia, hypospermia,
         exacerbation of preexisting arthritis; drowsiness, dizziness, light-headedness, depression, headache, reversible con-
         fusion states, paranoid psychosis; rash, Stevens-Johnson syndrome, reversible alopecia, gynecomastia, galactor-
         rhea, reversible impotence
         Interactions: Decreases hepatic metabolism of warfarin, phenobarbital, phenytoin, diazepam, propranolol, lidocaine,
         theophylline, thus increasing their activity and toxicity; antacids may decrease absorption




















                                           2025 RANGER MEDIC HANDBOOK  149
   158   159   160   161   162   163   164   165   166   167   168